New drug candidates for depression – a nationwide population‐based study - Kessing, L.V.; Rytgaard, H. C.; Gerds, T. A.; Berk, M.; Ekstrøm, C. T.; Andersen, P. K. (Acta psychiatrica Scandinavica, 2019)
Keywords: Adult; Aged; Allopurinol; Allopurinol - adverse effects; Allopurinol - therapeutic use; Angiotensin; Angiotensins - adverse effects; Angiotensins - therapeutic use; Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Antidepressants; Antidepressive Agents - therapeutic use; Aspirin; Aspirin - adverse effects; Aspirin - therapeutic use; Denmark - epidemiology; Depression - diagnosis; Depression - drug therapy; Depression - epidemiology; depressive disorder; Depressive Disorder - diagnosis; Depressive Disorder - drug therapy; Depressive Disorder - epidemiology; Diagnosis; Drug development; Drug dosages; Drug Repositioning - methods; Drug Repositioning - statistics & numerical data; drug repurposing; Female; Gout Suppressants - adverse effects; Gout Suppressants - therapeutic use; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use; Incidence; inflammation; Inflammation - drug therapy; Male; Mental depression; Middle Aged; Nonsteroidal anti-inflammatory drugs; NSAID; Outcome Assessment, Health Care; Population; Population studies; Population-based studies; Registries; Statins; stress; Stress, Physiological - drug effects; Denmark; stress; drug repurposing; inflammation; NSAID; statins; angiotensin; depressive disorder; aspirin; antidepressants; allopurinol